Related by context. Frequent words. (Click for all words.) 73 Nile Therapeutics 65 immunologic diseases 63 commercializing therapeutic 63 vascular disorders 63 acute decompensated heart 62 immuno inflammatory diseases 61 Pervasis 60 Nasdaq VRTX 60 Mipomersen 60 Inc. NASDAQ ABMD 59 Metabasis Therapeutics Inc. 59 phase IIb clinical 59 VIA Pharmaceuticals 58 cardiovascular metabolic 58 ATL# [001] 58 bucindolol 58 fibrotic diseases 58 oncology therapeutics 58 EPIX Pharmaceuticals Inc. 58 secondary hyperparathyroidism 57 endocrine diseases 57 HepaLife 57 Bicifadine 57 Genaera Corporation 57 diagnostic biomarkers 57 Applied NeuroSolutions 57 NYHA Class II 57 non alcoholic steatohepatitis 57 Sonus Pharmaceuticals 57 TransMolecular 57 urological disorders 57 Celsion Corporation 57 novel antibody therapeutics 57 human antibody therapeutics 56 multiple sclerosis rheumatoid arthritis 56 Celator 56 inflammation autoimmune diseases 56 NASDAQ IMCL 56 Addrenex 56 bio therapeutics 56 Adeona Pharmaceuticals Inc. 56 Panzem R 56 cancer immunotherapies 56 immunotherapeutics 56 Hybridon 56 Desmoteplase 56 commercializing novel 56 retinal disorders 56 peptide therapeutics 56 idiopathic pulmonary fibrosis IPF 56 degenerative disorders 56 BiPar 56 OncoGenex Pharmaceuticals Inc. 56 Aradigm Corporation 56 Ore Pharmaceuticals 56 Tranzyme 56 Response Genetics Inc. 56 novel therapeutics 56 Neurogen Corporation 56 Promedior 56 Viprinex 56 MicroDose 56 lung fibrosis 56 deforolimus 56 theranostics 56 chronic neuropathic pain 56 CNS disorders 55 EnVivo Pharmaceuticals 55 Lipid Sciences Inc. 55 TSX AEZ 55 PharmaFrontiers 55 molecular biomarkers 55 Tranzyme Pharma 55 inflammatory autoimmune 55 arterial thrombosis 55 stem cell therapeutics 55 Transave 55 Rexahn Pharmaceuticals Inc. 55 therapeutic peptides 55 Idera Pharmaceuticals 55 NASDAQ CBST 55 microRNA therapeutics 55 nitric oxide donating 55 Sunesis Pharmaceuticals 55 NASDAQ ARIA 55 Pirfenidone 55 Inc. NASDAQ CLDA 55 PsychoGenics 55 Dynavax Technologies Corporation 55 Ardea Biosciences 55 Phase IIb trials 55 molecular profiling 55 SciClone Pharmaceuticals Inc. 55 ophthalmic diseases 55 Gemin X 55 Medgenics 55 AA amyloidosis 55 Palatin Technologies Inc. 55 Regado 55 Ceregene 55 antisense drug